IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo

被引:54
|
作者
Aung, S
Graham, BS
机构
[1] Vanderbilt Univ, Sch Med, Dept Microbiol & Immunol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37232 USA
来源
JOURNAL OF IMMUNOLOGY | 2000年 / 164卷 / 07期
关键词
D O I
10.4049/jimmunol.164.7.3487
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CTL have evolved two major mechanisms for target cell killing: one mediated by perforin/granzyme secretion and the other by Fas/Fas ligand (L) interaction, Although cytokines are integral to the development of naive CTL into cytolytic effecters, the role of cytokines on mechanisms of CTL killing is just emerging, In this study, we evaluate the effects of IL-4 in Fas(CD95)/ FasL(CD95L)-mediated killing of Fas-overexpressing target cells, Recombinant vaccinia viruses (vv) were constructed to express respiratory syncytial virus M2 Ag alone (vvM2) or coexpress M2 and IL-4 (vvM2/IL-4). MHC-matched Fas-overexpressing target cells (L1210Fas(+)) were used to measure both perforin- and Fast-mediated killing pathways. In contrast to Fas-deficient (L1210Fas(-)) target cells, effecters from vvM2/IL-4-immunized mice were able to lyse L1210Fas(+) target cells with similar magnitude as vvM2-infected mice. Addition of EGTA/Mg2+ revealed that effecters from vvM2/IL-4-infected mice primarily lyse targets by a Ca2+-independent Fas/FasL pathway. Analysis of Fast expression by flow cytometry showed that IL-4 increased cell surface Fast expression on CD4+ and CD8+ splenocytes, with peak expression on day 4 after infection. These data demonstrate that IL-4 increases Fast expression on T cells, resulting in a shift of the mechanism of CTL killing from a dominant perforin-mediated cytolytic pathway to a dominant Fast-mediated cytolytic pathway.
引用
收藏
页码:3487 / 3493
页数:7
相关论文
共 50 条
  • [1] Perforin and Fas/Fas ligand-mediated cytotoxicity in acute and chronic woodchuck viral hepatitis
    Hodgson, PD
    Grant, MD
    Michalak, TI
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (01): : 63 - 70
  • [2] Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
    Brossart, P
    Bevan, MJ
    JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (06): : 2449 - 2458
  • [3] Fas ligand (CD95L) protects neurons against perforin-mediated T lymphocyte cytotoxicity
    Medana, I
    Li, ZX
    Flügel, A
    Tschopp, J
    Wekerle, H
    Neumann, H
    JOURNAL OF IMMUNOLOGY, 2001, 167 (02): : 674 - 681
  • [4] Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury
    Watanabe, Y
    Morita, M
    Akaike, T
    HEPATOLOGY, 1996, 24 (03) : 702 - 710
  • [5] Expression of high levels of human proteinase inhibitor 9 blocks both perforin/granzyme and Fas/Fas ligand-mediated cytotoxicity
    Cunningham, Thomas D.
    Jiang, Xinguo
    Shapiro, David J.
    CELLULAR IMMUNOLOGY, 2007, 245 (01) : 32 - 41
  • [6] Perforin-mediated cytotoxicity is critical for surveillance of spontaneous lymphoma
    Smyth, MJ
    Thia, KYT
    Street, SEA
    MacGregor, D
    Godfrey, DI
    Trapani, JA
    JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 192 (05): : 755 - 760
  • [7] In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor
    Connolly, K
    Cho, YH
    Duan, R
    Fikes, J
    Gregorio, T
    Lafleur, DW
    Okoye, Z
    Salcedo, TW
    Santiago, G
    Ullrich, S
    Wei, P
    Windle, W
    Wong, E
    Yao, XT
    Zhang, YQ
    Zheng, G
    Moore, PA
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2001, 298 (01): : 25 - 33
  • [8] Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection
    Anna Malyshkina
    Elisabeth Littwitz-Salomon
    Kathrin Sutter
    Gennadiy Zelinskyy
    Sonja Windmann
    Simone Schimmer
    Annette Paschen
    Hendrik Streeck
    Kim J. Hasenkrug
    Ulf Dittmer
    Scientific Reports, 7
  • [9] Fas Ligand-mediated cytotoxicity of CD4+T cells during chronic retrovirus infection
    Malyshkina, Anna
    Littwitz-Salomon, Elisabeth
    Sutter, Kathrin
    Zelinskyy, Gennadiy
    Windmann, Sonja
    Schimmer, Simone
    Paschen, Annette
    Streeck, Hendrik
    Hasenkrug, Kim J.
    Dittmer, Ulf
    SCIENTIFIC REPORTS, 2017, 7
  • [10] FAS ligand-mediated liver disease in mice
    Bobé, P
    Bonardelle, D
    Grandjon, D
    Godeau, F
    Joulin, V
    Tricottet, V
    Reynès, M
    Kiger, N
    10TH INTERNATIONAL CONGRESS ON IMMUNOLOGY, VOLS 1 AND 2, 1998, : 1065 - 1071